CMAX Clinical Research Email Format

Research ServicesSouth Australia, Australia201-500 Employees

CMAX Clinical Research, established in 1993, is among Australia’s largest and most experienced clinical trial operators, specializing in early-phase research. Its 78-bed facility in Adelaide’s Bio-Med City supports Phase I–II studies and has completed more than 200 first-in-human trials. The organization maintains a large participant database, comprising over 70,000 individuals, to support diverse recruitment for high-quality studies. All trials are conducted in accordance with ICH GCP and meet the requirements of major regulators, including the US FDA, EMEA, Japan’s MHW, and Health Canada, and the site has been subject to US FDA audits.

Based in Adelaide, South Australia, CMAX serves sponsors seeking reliable early-phase clinical trial capabilities with robust regulatory compliance and access to a broad participant pool. In December 2024, CMAX announced a partnership with Holoclara Inc to conduct a trial in Australia, in collaboration with Novotech, illustrating ongoing collaboration within the clinical research ecosystem.

Get verified CMAX Clinical Research emails free

Company overview Employee directory